Update on the immunosenescence: Humoral and cell-mediated immunity

Revista Brasileira de Medicina

Volumn 60, Issue 10, 2003, Pages 782-787

  Santana Santos, Franklin ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elderly; Humoral and cell mediated immunity; Immunosenescence

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 2; RECOMBINANT GAMMA INTERFERON;

AGED; AGING; ANTIBODY TITER; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; MEMORY CELL; NATURAL KILLER CELL; REVIEW; SENESCENCE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

EID: 0242362062     PISSN: 00347264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Thoman ML, Weigle WO: The cellular and subcellular basis of Immunosenescence. Adv Immunol 1989; 46:221.
2. Osmond DG: Population dynamics of bone marrow B-lymphocytes. Immunol Rev 1986; 93:103.
3. Miller RA: Immunodeficiency of aging: Restorative effects of phorbol myristate combined with calcium ionophore. J Immunol 1986; 137:805.
4. Timonen T, Saksela E, Ranki, Et al: Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell line targets. Cell Immunol 1979; 48:133.
5. Kay MMB: Immunodeficiency in old age. In Chandra RK (ed): Primary and Secondary Immunodeficiency Disorders. Edinburgh, Churchill Livingstone, 1983; p 165.
6. Weksler ME, Huterreroth TH: Impaired lymphocyte function in aged humans. J Clin Invest 1974; 53:99.
7. Kishimoto S, Takahama T, Mizumachi H: In vitro immune response to 2,4,6, trinitrophenol determinant in aged C57BL/6J mice: Changes in the humoral response to and avidity for the TNP determinant and responsiveness to LPS effect with aging. J Immunol 1976; 116:294.
8. Naor D, Bonavida B, Walford RL: Autoimmunity and aging: The age-related response of mice of a long-lived strain to trinitrophenylated syngeneic mouse red blood cells. J Immunol 1976; 117:2204.
9. Kallif MW: A population study on serum immunoglobulin levels. Clin Chim Acta 1970; 28:277.
10. Stutman O: Post-thymic T-cell development. Immunol Rev 1986; 91:159.
11. Weksler ME, Innes JB, Goldstein G: Immunological studies of aging. V. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin. J Exp Med 1978; 148:996.
12. Scollay RG, Butcher EC, Weissman IL: Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol 1980; 10:210.
13. Makinodan T, Kay MMB: Age influence on the immune system. Adv Immunol 1980; 29:287.
14. Proust JJ, Filburn CR, Harrison SA, et al: Age-related defect in signal transduction during lectin activation of murine T Lymphocytes. J Immunol 1987; 139:1472.
15. Ernst DN, Weigle WO, McQuitty DN et al: Stimulation of murine T cells subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules. J Immunol 1989; 142:1413.
16. Bottomly K: Subsets of CD4 T cells and B cells activation. Semin Immunol 1:21.1989
17. Miller RA: Age-associated decline in precursor frequency for different cell-mediated reactions with preservation of helper or cytotoxic effect per precursor cell. J Immunol 1984; 132:63.
18. Thoman ML, Weigle WO: Partial restoration of Con A -induced proliferation, IL-2 receptor expression, and IL-2 synthesis in aged murine lymphocytes by phorbol myristate acetate and ionomycin. Cell Immunol 1988; 114:1.
19. Vie H, Miller RA: Decline in age in the proportion of mouse T cells that express IL-2 receptors after mitogen stimulation. Mech Ageing Dev 1986; 33:313.
20. Thoman ML: Impaired responsiveness of IL-2 receptor-expressing T lymphocytes from aged mice. Cell Immunol 1991; 135:410.
21. Beckman I, Dimopoulos K, Xu X et al: Age-related changes in the activation requirements of human CD4 T-cell subsets. Cell Immunol 1991; 132:17.
22. Daynes RA, Araneo BA: Prevention and reversal of some age-asociated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging: Immunology and Infectious Disease 1992; 3:135.
23. Daynes RA, Dudley DJ, Araneo BA: Regulation of murine lymphokine production in vivo. II. Dehydroepiansterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 1990; 20:793.
24. Ernst DN, Hobbs MV, Torbett BE, et al: Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion of splenic CD4 T cells from young and aged mice. J Immunol 1990; 145:1295.
25. DePaoli P, Battisstin S, Santini GF: Age-related changes in human lymphocyte subsets: Progressive reduction of the CD4 CD45R (suppressor inducer) population. Clin Immunol Immunopathol 1988; 19:977.
26. Serra HM, Krowka JF, Ledbetter JA et al: Loss of CD45 (Lp220) represents a post-thymic T cell differentiation event. J Immunol 1988; 140:1435.
27. Walker C, Gouchet J-F, DeWeck AL, et al: Analysis of leukocyte markers in elderly individuals. Aging: Immunology and Infectious Disease 1990; 2:31.
28. Braciale T, Braciale V: Antigen presentation: Structural themes and functional variations. Immunol Today 1991; 12:124.
29. Cohen J: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992; 10:267.
30. Duke R: Apoptosis in cell-mediated immunity. In: Apoptosis: The Molecular Basis of cell death. Cold Spring Harbor, NY, Cold Spring Harbor Laboaratory Press, 1991, p 209.
31. Abo T, Balch C: A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981; 127:1024.
32. th International Leukocyte Conference, Alberta, Canada, 1988.
33. Tilden AB, Grossi CE, Itoh K, et al: Subpopulation analysis of human granular lymphocytes: Association with age, gender and cytotoxic activity. Nat Immun Cell Growth Reg 1986; 5:90.
34. Krishnaraj R, Blandford G: Quantitative and qualitative differences in natural killer cell activity in aging (abstract). Gerontologist 1984; 24:113.
35. Krishnaraj R, Blandford G: Age-associated alterations in human natural killer cells. Cell Immunol 1988; 114:137.
36. Ligthart GL, Schuit HRE, Hijmans W: Subpopulation of mononuclear cells in aging; expansion of the null cell compartment and decrease in the number of T and B cells in human blood. Immunology 1985; 55:15.
37. Facchini A, Mariani E, Mariana AR, et al: Increased number of circulating Leu 11+(CD16) large granular lymphocytes and decreased NK activity during human aging. Clin Exp Immunol 1987; 68:340.
38. Goto M, Nishioka KI: Age and sex-related changes of the lymphocyte subsets in healthy individuals: An analysis by two-dimensional flow cytometry. J Gerontol 1989; 44:M51.
39. Abo T, Cooper M, Balch CM: Postnatal expansion of the natural killer and killer cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med 1982; 155:321.
40. Anderson P, Viver E: Structure and function of the CD16: delta: gamma NK receptor complex. In: Lotzova E(ed): NK cell Mediated cytotoxicity: Receptors, Signalling and Mechanisms. Boca Raton, CRC Press, 1992, p 15.
41. Barlozzari T, Leonhardt J, Wiltrout R, et al: Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 1985; 134:2783.
42. Batory G, Benczur M, Varga M, et al: Increased killer cell activity in aged humans. Immunobiology 1981; 158:393.
43. Fernandes G, Gupta S: Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J Clin Immunol 1981; 1(3):141.
44. Krishnaraj R: Age-associated alterations in human natural killer cells. Clin Immunol Immunopathol 1987; 45:268.
45. Krishnaraj R: Preferential accumulation of mature NK cells during human Immunosenescence. J Cell Biochem 1982; 50:386.
46. Ligthart GL, Schuit HRE, Hijmans W: Natural killer cell function is not diminished in healthy aged and is proportional to the number of NK cells in the peripheral blood. Immunology 1992; 68:396.
47. Nagel JE, Collins GD, Alder WA: Spontaneous or natural killer cytotoxicity of K562 erythrleukemic cells in normal patients. Cancer Res 1981; 41:2284.
48. Kaufman D, Schoon R, Leibson P: MHC Class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J Immunol 1993; 150:1429.
49. Kay MB, Makinodan I: Immunology of aging: Evaluation of current status. Clin Immunol Immunopathol 1976; 6:394.